Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javle

Showing results (311-320 of 343) with videos related to

Pageof 35
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 30, 2026
A randomized phase 2 study of combination atezolizumab and varlilumab (CDX-1127) with or without cobimetinib in previously-treated unresectable biliary tract cancerThatcher Ross Heumann, Jiayun Lu, Hao Wang, et al.
JCO Global Oncology|November 21, 2024
Deep Diving Into the Fusion Across Cancer Types in the Indian Population From Formalin-Fixed Paraffin-Embedded RNA-Exome Data: A Road to Discovering Novel Rearrangements With Clinical RelevanceSatya Prakash Khuntia, Nilesh Mukherjee, Vyomesh Javle, et al.
Research Square|February 6, 2026
Tumor microenvironment changes after treatment with avelumab and immune- stimulating agent combinations in patients with advanced solid tumorsNejla Ozirmak Lermi, Mohamed A Gouda, Jibran Ahmed, et al.
Journal of Immunotherapy and Precision Oncology|June 6, 2022
Implementation of a Novel Web-Based Lesion Selection Tool to Improve Acquisition of Tumor Biopsy SpecimensMingxuan Xu, Coya Tapia, Joud Hajjar, et al.
Journal of Personalized Medicine|December 24, 2021
Benchmarking Outcomes after Ablative Radiotherapy for Molecularly Characterized Intrahepatic CholangiocarcinomaBrian De, Ibrahim Abu-Gheida, Aashini Patel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 2015
Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic CholangiocarcinomaTheodore S Hong, Jennifer Y Wo, Beow Y Yeap, et al.
The Lancet. Oncology|May 17, 2020
Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 studyGhassan K Abou-Alfa, Teresa Macarulla, Milind M Javle, et al.
The Journal of Clinical Investigation|January 20, 2016
TGF-β/β2-spectrin/CTCF-regulated tumor suppression in human stem cell disorder Beckwith-Wiedemann syndromeJian Chen, Zhi-Xing Yao, Jiun-Sheng Chen, et al.
Annals of Surgery|April 7, 2023
Effects of a Pragmatic Home-based Exercise Program Concurrent With Neoadjuvant Therapy on Physical Function of Patients With Pancreatic Cancer: The PancFit Randomized Clinical TrialAn T Ngo-Huang, Nathan H Parker, Lianchun Xiao, et al.
Journal of Gastrointestinal Oncology|January 13, 2017
Advances in cholangiocarcinoma research: report from the third Cholangiocarcinoma Foundation Annual ConferenceGhassan K Abou-Alfa, Jesper B Andersen, William Chapman, et al.
Pageof 35

Showing results (311-320 of 343) with videos related to

Sort By:
Pageof 35
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 30, 2026
A randomized phase 2 study of combination atezolizumab and varlilumab (CDX-1127) with or without cobimetinib in previously-treated unresectable biliary tract cancerThatcher Ross Heumann, Jiayun Lu, Hao Wang, et al.
JCO Global Oncology|November 21, 2024
Deep Diving Into the Fusion Across Cancer Types in the Indian Population From Formalin-Fixed Paraffin-Embedded RNA-Exome Data: A Road to Discovering Novel Rearrangements With Clinical RelevanceSatya Prakash Khuntia, Nilesh Mukherjee, Vyomesh Javle, et al.
Research Square|February 6, 2026
Tumor microenvironment changes after treatment with avelumab and immune- stimulating agent combinations in patients with advanced solid tumorsNejla Ozirmak Lermi, Mohamed A Gouda, Jibran Ahmed, et al.
Journal of Immunotherapy and Precision Oncology|June 6, 2022
Implementation of a Novel Web-Based Lesion Selection Tool to Improve Acquisition of Tumor Biopsy SpecimensMingxuan Xu, Coya Tapia, Joud Hajjar, et al.
Journal of Personalized Medicine|December 24, 2021
Benchmarking Outcomes after Ablative Radiotherapy for Molecularly Characterized Intrahepatic CholangiocarcinomaBrian De, Ibrahim Abu-Gheida, Aashini Patel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 2015
Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic CholangiocarcinomaTheodore S Hong, Jennifer Y Wo, Beow Y Yeap, et al.
The Lancet. Oncology|May 17, 2020
Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 studyGhassan K Abou-Alfa, Teresa Macarulla, Milind M Javle, et al.
The Journal of Clinical Investigation|January 20, 2016
TGF-β/β2-spectrin/CTCF-regulated tumor suppression in human stem cell disorder Beckwith-Wiedemann syndromeJian Chen, Zhi-Xing Yao, Jiun-Sheng Chen, et al.
Annals of Surgery|April 7, 2023
Effects of a Pragmatic Home-based Exercise Program Concurrent With Neoadjuvant Therapy on Physical Function of Patients With Pancreatic Cancer: The PancFit Randomized Clinical TrialAn T Ngo-Huang, Nathan H Parker, Lianchun Xiao, et al.
Journal of Gastrointestinal Oncology|January 13, 2017
Advances in cholangiocarcinoma research: report from the third Cholangiocarcinoma Foundation Annual ConferenceGhassan K Abou-Alfa, Jesper B Andersen, William Chapman, et al.
Pageof 35